Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets

Biomaterials

Volumn 32, Issue 27, 2011, Pages 6487-6492

  Luan, Nguyen Minh ^a   Teramura, Yuji ^b   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Heparin; Human soluble form complement receptor 1 (sCR1); Instant blood mediated inflammatory reaction (IBMIR); Islet transplantation; Poly(ethylene glycol) conjugated phospholipid

Indexed keywords

ANTI-COAGULATION; BLOOD COAGULATION; COIMMOBILIZATION; HEPARIN; HUMAN SOLUBLE FORM COMPLEMENT RECEPTOR 1 (SCR1); INFLAMMATORY REACTION; ISLET TRANSPLANTATION; LAYER-BY-LAYERS; THIOL GROUPS;

BLOOD; COAGULATION; ETHYLENE; GLYCOLS; GRAFTING (CHEMICAL); GRAFTS; LIPID BILAYERS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS;

POLYSACCHARIDES;

COMPLEMENT COMPONENT C3B RECEPTOR; HEPARIN; INSULIN; MACROGOL; MALEIMIDE; PHOSPHOLIPID; THIOL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROTECTION; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; FIBRINOLYSIS; HEMOLYSIS; INSULIN RELEASE; LIPID BILAYER; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOTOXICITY, IMMUNOLOGIC; GLUCOSE; HEPARIN; HUMANS; IMMOBILIZED PROTEINS; INSULIN; ISLETS OF LANGERHANS; MALE; PROTECTIVE AGENTS; PROTEIN BINDING; RATS; RECEPTORS, COMPLEMENT; SURFACE PLASMON RESONANCE; SURFACE PROPERTIES; THROMBIN;

EID: 79960075518     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.048     Document Type: Article

References (30)

1. Van der Windt D.J., Bottino R., Casu A., Campanile N., Cooper D.K. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007, 14(4):288-297.
2. Johansson H., Lukinius A., Moberg L., Lundgren T., Berne C., Foss A., et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54(6):1755-1762.
3. Bennet W., Groth C.G., Larsson R., Nilsson B., Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 2000, 105(2):125-133.
4. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
5. Pruitt S.K., Kirk A.D., Bollinger R.R., Marsh H.C., Collins B.H., Levin J.L., et al. The effect of soluble complement receptor 1 on hyperacute rejection of porcine xenografts. Transplantation 1994, 57:363-370.
6. Bennet W., Sundberg B., Lundgren T., Tibell A., Groth C.G., Richards A., et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000, 69:711-719.
7. Lam T.T., Hausen B., Hook L., Lau M., Higgins J., Christians U., et al. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Xenotransplantation 2005, 12:20-29.
8. Cui W., Angsana J., Wen J., Chaikof E.L. Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation. Cell Transplant 2010, 19(11):1359-1367.
9. Xie D., Smyth C.A., Eckstein C., Bilbao G., Mays J., Eckhoff D.E., et al. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 2005, 26(4):403-412.
10. Cabric S., Sanchez J., Lundgren T., Foss A., Felldin M., Källen R., et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007, 56(8):2008-2015.
11. Cheung C.Y., Anseth K.S. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 2006, 17:1036-1042.
12. Miura S., Teramura Y., Iwata H. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 2006, 27:5828-5835.
13. Teramura Y., Iwata H. Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug Chem 2008, 19(7):1389-1395.
14. Teramura Y., Iwata H. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 2009, 88(5):624-630.
15. Teramura Y., Iwata H. Cell surface modification with polymers for biomedical studies. Soft Matter 2010, 6:1081-1091.
16. Teramura Y., Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev 2010, 62(7-8):827-840.
17. Totani T., Teramura Y., Iwata H. Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains. Biomaterials 2008, 29(19):2878-2883.
18. Chen H., Teramura Y., Iwata H. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J Control Release 2011, 150(2):229-234.
19. Luan N.M., Teramura Y., Iwata H. Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials 2010, 31(34):8847-8853.
20. Luan N.M., Teramura Y., Iwata H. Immobilization of the soluble domain of human complement receptor 1 on islets. Biomaterials 2010, 31(34):8847-8853.
21. Swift A.J., Collins T.S., Bugelski P., Winkelstein J.A. Soluble human complement receptor type 1 inhibits complement-mediated host defense. Clin Diagn Lab Immunol 1994, 1(5):585-589.
22. Pratt J.R., Hibbs M.J., Laver A.J., Smith R.A., Sacks S.H. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 1996, 149(6):2055-2066.
23. Kato H., Inoue T., Ishii N., Murakami Y., Matsumura M., Seya T., et al. Novel simple method to purify recombinant soluble human complement receptor type 1 (sCR1) from CHO cell culture. Biotechnol Bioprocess Eng 2002, 7:67-75.
24. Hirata I., Morimoto Y., Murakami Y., Iwata H., Kitano E., Kitamura H., et al. Study of complement activation on well-defined surfaces using surface plasmon resonance. Colloids Surf B 2000, 18:285-292.
25. Lacy P.E., Kostianovky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
26. Bretzel R.G., Hering B.J., Federlin K.F. Assessment of adult islet preparations. Methods in cell transplantation 1995, 455-464. RG Landes, Austin, TX. C. Ricordi (Ed.).
27. Villiger P., Ryan E.A., Owen R., O'Kelly K., Oberholzer J., Al Saif F., et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005, 5:2992-2998.
28. Seya T., Holers V.M., Atkinson J.P. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J Immunol 1985, 135:2661-2667.
29. Airenne K.J., Marjomäki V.S., Kulomaa M.S. Recombinant avidin and avidin-fusion proteins. Biomol Eng 1999, 16(1-4):87-92.
30. Pan M., Lezo J.S., Medina A., Romero M., Hernandez E., Segura J., et al. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997, 80:1336-1338.